Comparing two types of tube feeding in patients with severe swallowing difficulties

ISRCTN ISRCTN17642761
DOI https://doi.org/10.1186/ISRCTN17642761
Secondary identifying numbers PEG/RIG 2014-281
Submission date
28/12/2021
Registration date
04/01/2022
Last edited
01/03/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
In patients suffering from severe and chronic dysphagia (swallowing difficulties), a feeding gastrostomy (a special tube placed directly into the stomach) can provide nutritional support. At present, two different types are in clinical use, one type placed by gastroscopy (percutaneous endoscopic gastrostomy [PEG], using a thin, flexible tube called an endoscope) and another type placed using x-ray vision (radiologically inserted gastrostomy [RIG]). The selection of patients to PEG or RIG is often based on rather poorly defined patient factors. The aim of this study is to compare PEG and RIG concerning overall complications, divided into major and minor complications as well as changes in patient-scored health status.

Who can participate?
Patients referred for a feeding gastrostomy and eligible for both methods

What does the study involve?
Participants are randomly allocated to undergo PEG or RIG and are followed up at 10 days in the out-patient department as well as by questionnaire at 30 days after surgery.

What are the possible benefits and risks of participating?
Benefits include an extended and standardised follow up. There are no added risks as both procedures are performed in routine care.

Where is the study run from?
Uppsala University Hospital (Sweden)

When is the study starting and how long is it expected to run for?
March 2013 to December 2022

Who is funding the study?
Uppsala University Hospital (Sweden)

Who is the main contact?
Prof. Magnus Sundbom
magnus.sundbom@surgsci.uu.se

Contact information

Prof Magnus Sundbom
Scientific

Dept of Surgical Sciences
Uppsala University
Uppsala
SE-75185
Sweden

Phone +46 (0)705432989
Email magnus.sundbom@surgsci.uu.se
Prof Magnus Sundbom
Principal Investigator

Dept of Surgical Sciences
Uppsala University
Uppsala
SE-75185
Sweden

Phone +46 (0)705432989
Email magnus.sundbom@surgsci.uu.se
Prof Magnus Sundbom
Public

Dept of Surgical Sciences
Uppsala University
Uppsala
SE-75185
Sweden

Phone +46 (0)705432989
Email magnus.sundbom@surgsci.uu.se

Study information

Study designRandomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleA prospective randomized trial comparing percutaneous endoscopic gastrostomy to radiologically inserted percutaneous gastrostomy
Study acronymPEG-RIG
Study objectivesPercutaneous endoscopic gastrostomy (PEG) is superior to radiologically inserted gastrostomy (RIG) based on overall complications
Ethics approval(s)Approved 21/09/2014, the Regional Ethics Committee of Uppsala (Etikprövningsmyndigheten, Box 2110, SE-750 02 Uppsala, Sweden; +46 (0)8 4587070; registrator@etikprovning.se), ref: Dnr: 2014-281
Health condition(s) or problem(s) studiedSevere dysphagia
InterventionParticipants are randomly allocated 1:1 in blocks of 10 with closed envelopes to undergo percutaneous endoscopic gastrostomy (PEG) or radiologically inserted gastrostomy (RIG) and are followed up at 10 days in the out-patient department as well as by questionnaire at 30 days after surgery.
Intervention typeProcedure/Surgery
Primary outcome measureOverall complication rate and major and minor complications occurring early (within 10 days) or late (11-30 days) after gastrostomy placement. Major complications are defined as conditions in potential need of reoperation or cardiovascular support, e.g., gastrointestinal perforations, intrabdominal bleeding, aspiration pneumonia or myocardial infarction, while local and self-limiting problems are to be classified as minor.
Secondary outcome measuresPatient-scored health status measured by EQ-5D (EuroQol Research Foundation) at baseline and at 10 and 30 days postoperatively
Overall study start date14/03/2013
Completion date31/12/2022

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants180
Key inclusion criteriaPatients referred to the department for a feeding gastrostomy due to severe dysphagia, and eligible for both methods (PEG/RIG)
Key exclusion criteriaInability to perform an endoscopy due to pharyngo-esophageal obstruction, total or subtotal gastrectomy, other major upper-abdominal surgery, peritoneal carcinosis or ascites
Date of first enrolment01/10/2014
Date of final enrolment31/12/2021

Locations

Countries of recruitment

  • Sweden

Study participating centre

Uppsala University Hospital
Dept of Surgical Sciences
Uppsala University
Uppsala
SE-75185
Sweden

Sponsor information

Uppsala University Hospital
Hospital/treatment centre

VO Kirurgi
Dept of Surgical Sciences
Uppsala University
Uppsala
SE-75185
Sweden

Phone +46 (0)18 6110000
Email registrator@akademiska.se
Website http://www.akademiska.se/
ROR logo "ROR" https://ror.org/01apvbh93

Funders

Funder type

Hospital/treatment centre

Akademiska Sjukhuset
Private sector organisation / Universities (academic only)
Alternative name(s)
Uppsala University Hospital
Location
Sweden

Results and Publications

Intention to publish date31/12/2023
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPlanned publication in a high-impact peer.reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study are not expected to be made available due to patient confidentiality

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 28/02/2023 01/03/2023 Yes No

Editorial Notes

01/03/2023: Publication reference added.
29/12/2021: Trial's existence confirmed by the Regional Ethics Committee of Uppsala.